Figure 2
From: Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study
PD-L1 expression on TIMC and 5-Year survival rate (univariate analysis).
Figure 2 | Journal for ImmunoTherapy of Cancer
